BCR/ABL EXPRESSION IN CHRONIC MYELOPROLIFERATIVE DISORDERS

被引：0
|
作者：
Kesaeva, L. [1 ]
Misyurin, A. [1 ]
Misyurina, E. [1 ]
Krutov, A. [1 ]
Soldatova, I. [1 ]
Kaysina, K. [1 ]
机构：
[1] GeneTechnol LLC, Moscow, Russia
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P826
引用
收藏
页码：346 / 346
页数：1
相关论文
共 50 条
  • [21] Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
    Mesa, Ruben A.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (02): : 129 - 138
  • [22] Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders
    David, Marianna
    Cross, Nicholas C. P.
    Burgstaller, Sonja
    Chase, Andrew
    Curtis, Claire
    Dang, Raymond
    Gardembas, Martine
    Goldman, John M.
    Grand, Francis
    Hughes, George
    Huguet, Francoise
    Lavender, Louise
    McArthur, Grant A.
    Mahon, Francois X.
    Massimini, Giorgio
    Melo, Junia
    Rousselot, Philippe
    Russell-Jones, Robin J.
    Seymour, John F.
    Smith, Graeme
    Stark, Alastair
    Waghorn, Katherine
    Nikolova, Zariana
    Apperley, Jane F.
    BLOOD, 2007, 109 (01) : 61 - 64
  • [23] GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
    Yang, Naery
    Park, Sholhui
    Cho, Min-Sun
    Lee, Miae
    Hong, Ki-Sook
    Mun, Yeung Chul
    Seong, Chu-Myong
    Huh, Hee Jin
    Huh, Jungwon
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (04) : 296 - +
  • [24] Routine fluorescence in situ hybridization analysis for detection of BCR-ABL rearrangement in myeloproliferative disorders
    Sabatino, G
    Calabrese, G
    Franchi, PG
    Stuppia, L
    Jadayel, D
    Donti, E
    Palka, G
    LEUKEMIA RESEARCH, 1997, 21 (06) : 581 - 583
  • [25] Genetic profiling of BCR/ABL negative myeloproliferative disorders using high-resolution microarrays
    Stegelmann, Frank
    Griesshammer, Martin
    Ruf, Sandra
    Kuhn, Susanne
    Rucker, Frank G.
    Miller, Simone
    Dohner, Hartmut
    Dohner, Konstanze
    BLOOD, 2007, 110 (11) : 460A - 460A
  • [26] Bcr-abl transcript identifiable at low levels in blood in all myeloproliferative disorders.
    Singer, IO
    Sproul, A
    Tait, RC
    Soutar, R
    Gibson, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 94 - 94
  • [27] Testing in-vitro for imatinib sensitivity in BCR-ABL negative myeloproliferative disorders.
    Chase, A
    Higley, K
    Baxter, J
    Grand, F
    Grand, E
    Cross, NCP
    BLOOD, 2003, 102 (11) : 658A - 658A
  • [28] Expression of μ-BCR-ABL transcripts in chronic neutrophilic leukemia
    Cioc, AM
    Nuovo, GJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (06) : 842 - 847
  • [29] Allelic expression imbalance of JAK2 V617F mutant contributes to phenotypic variation in BCR-ABL negative chronic myeloproliferative disorders
    Shin, Myung-Geun
    Kim, Hye-Ran
    Kim, Hyeoung-Joon
    Kim, Miji
    Kim, Hee-Nam
    Kim, Yeo-Kyeoung
    Kim, Soo-Hyun
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    BLOOD, 2007, 110 (11) : 236B - 237B
  • [30] Inconsistency in the methylation status of ABL promoter in Ph-negative BCR-ABL positive and negative myeloproliferative disorders.
    Blickstein, D
    Aviram, A
    Witenberg, B
    Shaklai, M
    BLOOD, 2000, 96 (11) : 266B - 266B
12345